A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

Columvi achieved a 78.3% complete response rate and 85% overall response rate in relapsed/refractory mantle cell lymphoma ...

A trial evaluating the tamibarotene-Vidaza combination in certain patients with newly diagnosed high-risk MDS will be ...

Panelists discuss key advice for patients and caregivers navigating advanced prostate cancer, highlighting essential insights ...

Survivorship: it’s a positive word that elicits the idea of success, winning and, as a four-time cancer survivor myself, the ...

Panelists discuss the key takeaways from their experiences in treating advanced prostate cancer, emphasizing valuable lessons ...

COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic cancers. Patients resistant to prior immunotherapy showed the most benefit ...

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...

Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...

Maria Hicinbothem, Wandaris Ortiz, and Sandi Wetherbee—are being celebrated for their exceptional dedication to patient care, ...

When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, ...